The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Michael L. Curtin

Department of Cancer Research

Global Pharmaceutical Research and Development

Abbott Laboratories

Abbott Park

USA

[email]@abbott.com

Name/email consistency: medium

 
 
 
 
 
 
 

Affiliations

  • Department of Cancer Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, USA. 2003 - 2004
  • Abbott Laboratories, Abbott Park, IL 60064-6100, USA. 2004
  • Abbott Laboratories, R47J/AP10, 100 Abbott Park Rd, Abbott Park, USA. 2003
  • Cancer Research Area, Abbott Laboratories, Dept. 47J, Bldg. AP10, USA. 2001 - 2002
  • Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064-3500, USA. 1998

References

  1. Isoindolinone ureas: a novel class of KDR kinase inhibitors. Curtin, M.L., Frey, R.R., Heyman, H.R., Sarris, K.A., Steinman, D.H., Holmes, J.H., Bousquet, P.F., Cunha, G.A., Moskey, M.D., Ahmed, A.A., Pease, L.J., Glaser, K.B., Stewart, K.D., Davidsen, S.K., Michaelides, M.R. Bioorg. Med. Chem. Lett. (2004) [Pubmed]
  2. Synthesis of novel hydroxamate and non-hydroxamate histone deacetylase inhibitors. Curtin, M.L. Curr. Opin. Drug. Discov. Devel (2004) [Pubmed]
  3. Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase. Curtin, M.L., Florjancic, A.S., Cohen, J., Gu, W.Z., Frost, D.J., Muchmore, S.W., Sham, H.L. Bioorg. Med. Chem. Lett. (2003) [Pubmed]
  4. Histone deacetylase inhibitors: the Abbott experience. Curtin, M., Glaser, K. Curr. Med. Chem. (2003) [Pubmed]
  5. Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC). Curtin, M.L., Garland, R.B., Heyman, H.R., Frey, R.R., Michaelides, M.R., Li, J., Pease, L.J., Glaser, K.B., Marcotte, P.A., Davidsen, S.K. Bioorg. Med. Chem. Lett. (2002) [Pubmed]
  6. Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770. Curtin, M.L., Florjancic, A.S., Heyman, H.R., Michaelides, M.R., Garland, R.B., Holms, J.H., Steinman, D.H., Dellaria, J.F., Gong, J., Wada, C.K., Guo, Y., Elmore, I.B., Tapang, P., Albert, D.H., Magoc, T.J., Marcotte, P.A., Bouska, J.J., Goodfellow, C.L., Bauch, J.L., Marsh, K.C., Morgan, D.W., Davidsen, S.K. Bioorg. Med. Chem. Lett. (2001) [Pubmed]
  7. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists. Curtin, M.L., Davidsen, S.K., Heyman, H.R., Garland, R.B., Sheppard, G.S., Florjancic, A.S., Xu, L., Carrera, G.M., Steinman, D.H., Trautmann, J.A., Albert, D.H., Magoc, T.J., Tapang, P., Rhein, D.A., Conway, R.G., Luo, G., Denissen, J.F., Marsh, K.C., Morgan, D.W., Summers, J.B. J. Med. Chem. (1998) [Pubmed]
 
WikiGenes - Universities